Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-012132
Filing Date
2023-04-13
Accepted
2023-04-13 16:13:41
Documents
55
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 957686
2 ex1.htm EX-1 19977
3 ex31-1.htm EX-31.1 18597
4 ex31-2.htm EX-31.2 18946
5 ex32-1.htm EX-32.1 7010
6 ex1_001.jpg GRAPHIC 3394
7 ex1_002.jpg GRAPHIC 2439
  Complete submission text file 0001493152-23-012132.txt   4296269

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gcan-20221231.xsd EX-101.SCH 34892
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gcan-20221231_cal.xml EX-101.CAL 34503
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gcan-20221231_def.xml EX-101.DEF 176424
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gcan-20221231_lab.xml EX-101.LAB 263945
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gcan-20221231_pre.xml EX-101.PRE 223470
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 498604
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56027 | Film No.: 23818499
SIC: 2834 Pharmaceutical Preparations